Psychiatric Mental Health Nurse Practitioner
Neuronetics
Psychiatric Mental Health Nurse Practitioner
Neuronetics
Non-invasive TMS device for depression
About Us
Neuronetics, Inc. is a leading mental health company dedicated to transforming lives through innovative treatments. Now joined with Greenbrook Mental Wellness Centers, we offer FDA-cleared NeuroStar® TMS and Spravato® therapies for major depressive disorder and treatment-resistant depression across 95+ clinics nationwide. Together, we’re expanding access to life-changing care—combining cutting-edge technology with clinical expertise to make a real impact in the mental health space.
Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., is seeking a Board Certified or Board Eligible Nurse Practitioner to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the growth of our Spravato® (esketamine) program in Newport News, VA.
Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., is a leading provider of TMS and Spravato® therapies, delivering innovative, evidence-based treatments for depression, OCD, and other mental health conditions. Through a nationwide network of treatment centers, Greenbrook is helping patients find relief when traditional treatments have not been successful.
Join us in transforming mental health care and improving lives.
Learn More
Neuronetics, together with Greenbrook Mental Wellness Centers, delivers innovative mental health treatments through FDA-cleared NeuroStar® TMS and Spravato® therapies. Our mission is to expand access to life-changing care, combining cutting-edge technology, compassionate patient support, and clinical excellence to improve lives every day. Join us in making a meaningful impact in the rapidly growing mental health field.
GBSP25
[]
Non-invasive TMS device for depression
Neuronetics makes non-invasive neurostimulation devices for psychiatric disorders, led by the NeuroStar Advanced Therapy system that uses transcranial magnetic stimulation to treat mood disorders. Treatments are outpatient, short sessions with no anesthesia, targeting mood-regulation brain areas. Revenue comes from selling or leasing devices and selling single-use treatment components; after acquiring Greenbrook TMS, they also operate their own network of treatment centers. Their goal is to expand neuromodulation use, grow the installed base, and scale both device sales and clinics to help more patients.
Explore more opportunities at Neuronetics